- Report
- April 2025
- 140 Pages
Global
From €4258EUR$4,850USD£3,721GBP
- Report
- April 2025
- 130 Pages
Global
From €4258EUR$4,850USD£3,721GBP
- Clinical Trials
- April 2025
- 1432 Pages
Global
From €3029EUR$3,450USD£2,647GBP
- Report
- April 2025
- 48 Pages
Global
From €8776EUR$9,995USD£7,669GBP
- Report
- March 2025
- 132 Pages
Global
From €4258EUR$4,850USD£3,721GBP
- Report
- September 2025
- 247 Pages
United States
From €1624EUR$1,850USD£1,419GBP
- Report
- July 2025
- 150 Pages
United States
From €5224EUR$5,950USD£4,565GBP
- Report
- July 2025
- 100 Pages
United States
From €5224EUR$5,950USD£4,565GBP
- Report
- May 2025
- 125 Pages
North America
From €5224EUR$5,950USD£4,565GBP
- Report
- August 2025
- 200 Pages
United States
From €2186EUR$2,490USD£1,911GBP
- Report
- August 2025
- 123 Pages
North America
From €3511EUR$3,999USD£3,068GBP
- Report
- March 2025
- 84 Pages
Africa, Middle East
From €3029EUR$3,450USD£2,647GBP
- Report
- March 2025
- 89 Pages
Asia Pacific
From €3029EUR$3,450USD£2,647GBP
- Report
- October 2025
- 90 Pages
Middle East
From €4258EUR$4,850USD£3,721GBP
- Report
- August 2025
- 73 Pages
Africa, Middle East
From €3029EUR$3,450USD£2,647GBP
- Report
- August 2025
- 97 Pages
Asia Pacific
From €3468EUR$3,950USD£3,031GBP
- Report
- August 2025
- 98 Pages
Europe
From €3468EUR$3,950USD£3,031GBP
- Report
- August 2025
- 89 Pages
North America
From €3029EUR$3,450USD£2,647GBP
- Report
- April 2025
- 41 Pages
United States
- Report
- February 2024
- 280 Pages
Global
From €5152EUR$6,073USD£4,350GBP

The Dermatological Drugs market is a sector of the pharmaceutical industry that focuses on the development and production of drugs used to treat skin conditions. These drugs are used to treat a variety of skin conditions, including acne, eczema, psoriasis, and skin cancer. Dermatological drugs are typically administered topically, although some may be taken orally.
The Dermatological Drugs market is highly competitive, with many companies vying for market share. Major players in the market include Johnson & Johnson, GlaxoSmithKline, Pfizer, Merck, and Novartis. These companies are engaged in research and development of new drugs, as well as marketing and distribution of existing products. Additionally, many smaller companies are involved in the production of generic dermatological drugs. Show Less Read more